Richard Silvera - Infectious Disease | Icahn School of Medicine

Biography

Specialties

Infectious Disease

Education

MD, Icahn School of Medicine at Mount Sinai

Residency, Internal Medicine, Institution Not Present

Residency, Internal Medicine, Montefiore Medical Center

Fellowship, Infectious Disease, Icahn School of Medicine

Fellowship, Infectious Disease, Icahn School of Medicine At Mount Sinai

Certifications

American Board of Internal Medicine

Publications

17

Publications

Selected Publications

Host Nuclear Genome Copy Number Variations Identify High-Risk Anal Precancers in People Living with HIV. Tinaye Mutetwa, Yuxin Liu, Richard Silvera, Michelle Evans, Michael Yurich, Joseph Tripodi, Issa Leonard, Jane Houldsworth, Zeynep Gmş, Anne M. Bowcock, Keith Sigel, Michael Gaisa, Paz Polak. Journal of Acquired Immune Deficiency Syndromes

Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System. Christopher Vo, Rustin Zomorodi, Richard Silvera, Logan Bartram, Luz Amarilis Lugo, Erna Kojic, Antonio Urbina, Judith Aberg, Keith Sigel, Rachel Chasan, Gopi Patel. Open Forum Infectious Diseases

Everybody nose: molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infection. Erika Reategui Schwarz, Adriana van de Guchte, Amy C. Dupper, Ana Berbel Caban, Devika Nadkarni, Lindsey Fox, Alexandra Mills, Ajay Obla, Kieran I. Chacko, Irina Oussenko, Flora Samaroo, Jose Polanco, Richard Silvera, Melissa L. Smith, Gopi Patel, Melissa Gitman, Bremy Alburquerque, Marilyn Chung, Mitchell J. Sullivan, Harm van Bakel, Deena R. Altman. BMC Infectious Diseases

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Silvera has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Silvera has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.